These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34463936)
21. Synthesis and Hua S J Liposome Res; 2019 Dec; 29(4):357-367. PubMed ID: 30526169 [TBL] [Abstract][Full Text] [Related]
22. Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo. Li H; Yuan D; Sun M; Ping Q Drug Deliv; 2016 Nov; 23(9):3562-3572. PubMed ID: 27432585 [TBL] [Abstract][Full Text] [Related]
23. Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes. Wang J; Wu Z; Pan G; Ni J; Xie F; Jiang B; Wei L; Gao J; Zhou W Nanomedicine; 2018 Aug; 14(6):1949-1961. PubMed ID: 29045824 [TBL] [Abstract][Full Text] [Related]
24. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Hansen CB; Kao GY; Moase EH; Zalipsky S; Allen TM Biochim Biophys Acta; 1995 Nov; 1239(2):133-44. PubMed ID: 7488618 [TBL] [Abstract][Full Text] [Related]
25. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902 [TBL] [Abstract][Full Text] [Related]
26. Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor. Manjappa AS; Chaudhari KR; Venkataraju MP; Dantuluri P; Nanda B; Sidda C; Sawant KK; Murthy RS J Control Release; 2011 Feb; 150(1):2-22. PubMed ID: 21095210 [TBL] [Abstract][Full Text] [Related]
27. Antibody-labeled liposomes for CT imaging of atherosclerotic plaques: in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography. Danila D; Partha R; Elrod DB; Lackey M; Casscells SW; Conyers JL Tex Heart Inst J; 2009; 36(5):393-403. PubMed ID: 19876414 [TBL] [Abstract][Full Text] [Related]
28. Effect of lipid composition on incorporation of trastuzumab-PEG-lipid into nanoliposomes by post-insertion method: physicochemical and cellular characterization. Golkar N; Tamaddon AM; Samani SM J Liposome Res; 2016; 26(2):113-25. PubMed ID: 26023889 [TBL] [Abstract][Full Text] [Related]
29. Influences of different sugar ligands on targeted delivery of liposomes. Zhang C; Chen Z; Li W; Liu X; Tang S; Jiang L; Li M; Peng H; Lian M J Drug Target; 2020; 28(7-8):789-801. PubMed ID: 32242754 [TBL] [Abstract][Full Text] [Related]
30. Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. Carrion C; Domingo JC; de Madariaga MA Chem Phys Lipids; 2001 Nov; 113(1-2):97-110. PubMed ID: 11687230 [TBL] [Abstract][Full Text] [Related]
31. Immunoliposomes for Targeted Delivery of an Antifibrotic Drug. Schuster L; Seifert O; Vollmer S; Kontermann RE; Schlosshauer B; Hartmann H Mol Pharm; 2015 Sep; 12(9):3146-57. PubMed ID: 26181293 [TBL] [Abstract][Full Text] [Related]
32. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells. Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253 [TBL] [Abstract][Full Text] [Related]
33. Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity. Liu M; Li W; Larregieu CA; Cheng M; Yan B; Chu T; Li H; Mao SJ Mol Pharm; 2014 Jul; 11(7):2305-12. PubMed ID: 24830852 [TBL] [Abstract][Full Text] [Related]
38. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229 [TBL] [Abstract][Full Text] [Related]
39. Characterization and in vitro evaluation of nimotuzumab conjugated with cisplatin-loaded liposomes. Vázquez-Becerra H; Pérez-Cárdenas E; Muñiz-Hernández S; Izquierdo-Sánchez V; Medina LA J Liposome Res; 2017 Dec; 27(4):274-282. PubMed ID: 27367153 [TBL] [Abstract][Full Text] [Related]
40. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody. Pan H; Niu GQ; Pan J; Lu WY Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]